Steven Bander
Family Medicine · Blanchard, OKNPI 1578545026
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 157 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 17.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,161 and has fallen 96.4% since, to $42 in 2025.
Across 157 payments — averaging $21.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$585
- AbbVie$465
- Pfizer$323
- Boehringer Ingelheim$320
- Novo Nordisk$289
- GSK$218
- plus $1K from 23 others
What the payments were for
- Food & beverage$3,334100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 24 | $585 |
| AbbVie(2 entities) | 19 | $465 |
| Pfizer | 18 | $323 |
| Boehringer Ingelheim | 16 | $320 |
| Novo Nordisk | 10 | $289 |
| GSK | 15 | $218 |
| Johnson & Johnson | 8 | $210 |
| Lilly USA, LLC | 8 | $166 |
| Merck | 8 | $117 |
| Microport Orthopedics Inc | 1 | $105 |
| Eisai Inc. | 4 | $62 |
| Sanofi-aventis U.S. LLC | 3 | $44 |
| Astellas Pharma US Inc | 2 | $42 |
| Abbott | 2 | $41 |
| Esperion Therapeutics, Inc. | 2 | $39 |
| Sunovion Pharmaceuticals Inc. | 2 | $35 |
| Dexcom, Inc. | 2 | $32 |
| Sanofi Pasteur Inc. | 2 | $30 |
| Amgen | 1 | $28 |
| Edwards Lifesciences | 1 | $27 |
| Amarin Pharma, Inc. | 1 | $24 |
| Genentech USA, Inc. | 1 | $21 |
| Si-bone, Inc. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $16 |
| Dynavax Technologies Corporation | 1 | $16 |
| Ironshore Pharmaceuticals Inc. | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $14 |
| Biohaven Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Ozempic$125
- VRAYLAR$123
- FARXIGA$117
- MPO Medial Pivot Knee$105
How this compares
$3,334 in reported general payments places this provider in the 80th percentile of 1,730 family medicine providers in Oklahoma.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxepin Hcl | 18 | $485 |
| Quetiapine Fumarate | 12 | $129 |
| Alprazolam | 17 | $77 |
| Methylprednisolone | 11 | $68 |
| Pioglitazone Hcl | 12 | $64 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Blanchard
- Alexander FrankOklahoma City$3.1M
- Stanley ShadidEdmond$363K
- Geoffrey PlumleeTulsa$297K
- Curtis HarrisAda$125K
- Melinda CailOklahoma City$122K
- Jose Maria Borrego AcostaOklahoma City$106K
- Lisa ConneryNorman$105K
- Michael RobinsonElk City$84K
- Kimberly HuttonTulsa$76K
- James BeebeMuskogee$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.